Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Pariser

Showing results (71-80 of 115) with videos related to

Pageof 12
Sort By:
Journal of the American Academy of Dermatology|July 14, 2018
Topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Results from the ATMOS-1 and ATMOS-2 phase 3 randomized controlled trialsDee Anna Glaser, Adelaide A Hebert, Alexander Nast, et al.
Journal of the American Academy of Dermatology|April 4, 2018
Safety and efficacy of a fixed combination of halobetasol and tazarotene in the treatment of moderate-to-severe plaque psoriasis: Results of 2 phase 3 randomized controlled trialsLinda Stein Gold, Mark G Lebwohl, Jeffrey L Sugarman, et al.
American Journal of Clinical Dermatology|May 22, 2019
A 44-Week Open-Label Study Evaluating Safety and Efficacy of Topical Glycopyrronium Tosylate in Patients with Primary Axillary HyperhidrosisDee Anna Glaser, Adelaide A Hebert, Alexander Nast, et al.
Pediatric Dermatology|November 21, 2015
Scanning Electron Microscopic Hair Shaft Analysis in Ectodermal Dysplasia SyndromesStefanie A Hirano-Ali, Ashley M Reed, Brandon J Rowan, et al.
Journal of the American Academy of Dermatology|January 19, 2016
Long-term safety and efficacy of etanercept in children and adolescents with plaque psoriasisAmy S Paller, Elaine C Siegfried, David M Pariser, et al.
Dermatology and Therapy|July 8, 2021
The Proposed PASI-HD Provides More Precise Assessment of Plaque Psoriasis Severity in Anatomical Regions with a Low Area ScoreKim A Papp, Mark G Lebwohl, Leon H Kircik, et al.
Journal of the American Academy of Dermatology|November 27, 2012
Efinaconazole 10% solution in the treatment of toenail onychomycosis: Two phase III multicenter, randomized, double-blind studiesBoni E Elewski, Phoebe Rich, Richard Pollak, et al.
Journal of Cutaneous Medicine and Surgery|May 16, 2006
Clinical efficacy of efalizumab in patients with chronic plaque psoriasis: results from three randomized placebo-controlled Phase III trials: part IDavid M Pariser, Kenneth B Gordon, Kim A Papp, et al.
Journal of the American Academy of Dermatology|October 25, 2003
AAD consensus statement on psoriasis therapiesJeffrey P Callen, Gerald G Krueger, Mark Lebwohl, et al.
Journal of the American Academy of Dermatology|July 16, 2005
Tacrolimus ointment is safe and effective in the treatment of atopic dermatitis: results in 8000 patientsJohn Y M Koo, Alan B Fleischer, William Abramovits, et al.
Pageof 12

Showing results (71-80 of 115) with videos related to

Sort By:
Pageof 12
Journal of the American Academy of Dermatology|July 14, 2018
Topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Results from the ATMOS-1 and ATMOS-2 phase 3 randomized controlled trialsDee Anna Glaser, Adelaide A Hebert, Alexander Nast, et al.
Journal of the American Academy of Dermatology|April 4, 2018
Safety and efficacy of a fixed combination of halobetasol and tazarotene in the treatment of moderate-to-severe plaque psoriasis: Results of 2 phase 3 randomized controlled trialsLinda Stein Gold, Mark G Lebwohl, Jeffrey L Sugarman, et al.
American Journal of Clinical Dermatology|May 22, 2019
A 44-Week Open-Label Study Evaluating Safety and Efficacy of Topical Glycopyrronium Tosylate in Patients with Primary Axillary HyperhidrosisDee Anna Glaser, Adelaide A Hebert, Alexander Nast, et al.
Pediatric Dermatology|November 21, 2015
Scanning Electron Microscopic Hair Shaft Analysis in Ectodermal Dysplasia SyndromesStefanie A Hirano-Ali, Ashley M Reed, Brandon J Rowan, et al.
Journal of the American Academy of Dermatology|January 19, 2016
Long-term safety and efficacy of etanercept in children and adolescents with plaque psoriasisAmy S Paller, Elaine C Siegfried, David M Pariser, et al.
Dermatology and Therapy|July 8, 2021
The Proposed PASI-HD Provides More Precise Assessment of Plaque Psoriasis Severity in Anatomical Regions with a Low Area ScoreKim A Papp, Mark G Lebwohl, Leon H Kircik, et al.
Journal of the American Academy of Dermatology|November 27, 2012
Efinaconazole 10% solution in the treatment of toenail onychomycosis: Two phase III multicenter, randomized, double-blind studiesBoni E Elewski, Phoebe Rich, Richard Pollak, et al.
Journal of Cutaneous Medicine and Surgery|May 16, 2006
Clinical efficacy of efalizumab in patients with chronic plaque psoriasis: results from three randomized placebo-controlled Phase III trials: part IDavid M Pariser, Kenneth B Gordon, Kim A Papp, et al.
Journal of the American Academy of Dermatology|October 25, 2003
AAD consensus statement on psoriasis therapiesJeffrey P Callen, Gerald G Krueger, Mark Lebwohl, et al.
Journal of the American Academy of Dermatology|July 16, 2005
Tacrolimus ointment is safe and effective in the treatment of atopic dermatitis: results in 8000 patientsJohn Y M Koo, Alan B Fleischer, William Abramovits, et al.
Pageof 12